DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Improved glycemic control with no weight in-crease in patients with type 2 diabetes after once-daily treat-ment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.
 
Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > Effectivity of Administration Forms > Long-Acting GLP-1 Analog > Journal Article

Account Information